Health Logic Interactive Inc. (CHYPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -18.4 Thousand USD | 89.85% |
| 2022 | - USD | 63.45% |
| 2021 | - USD | -464.94% |
| 2020 | - USD | -432.79% |
| 2019 | -70.49 Thousand USD | 92.2% |
| 2018 | -951.93 Thousand CAD | 63.97% |
| 2017 | -1.93 Million CAD | -65.62% |
| 2016 | -1.16 Million CAD | -89.48% |
| 2015 | -858.27 Thousand CAD | -179.67% |
| 2014 | -1.33 Million CAD | 17.3% |
| 2013 | -266.56 Thousand CAD | -24.57% |
| 2012 | -213.99 Thousand CAD | 6.85% |
| 2011 | -229.73 Thousand CAD | -990.68% |
| 2010 | -21.06 Thousand CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -20.46 Thousand CAD | -396.22% |
| 2024 Q1 | -6636.42 USD | 67.64% |
| 2023 Q4 | -20.5 Thousand USD | -17.16% |
| 2023 Q3 | -17.5 Thousand USD | 5.79% |
| 2023 Q1 | -3593.48 USD | 98.85% |
| 2023 FY | - USD | 89.85% |
| 2023 Q2 | -18.58 Thousand USD | -417.05% |
| 2022 Q2 | -83.85 Thousand CAD | 54.08% |
| 2022 Q1 | -182.61 Thousand CAD | 72.83% |
| 2022 FY | - USD | 63.45% |
| 2022 Q4 | -313.61 Thousand USD | -781.42% |
| 2022 Q3 | -35.58 Thousand USD | 57.57% |
| 2021 Q2 | -977.74 Thousand CAD | -292.53% |
| 2021 FY | - USD | -464.94% |
| 2021 Q1 | -249.09 Thousand CAD | 2.31% |
| 2021 Q4 | -672.04 Thousand CAD | -102.94% |
| 2021 Q3 | -331.15 Thousand CAD | 66.13% |
| 2020 Q4 | -254.98 Thousand CAD | -154.87% |
| 2020 Q3 | -100.04 Thousand CAD | -331.74% |
| 2020 Q1 | -18.25 Thousand CAD | 53.03% |
| 2020 FY | - USD | -432.79% |
| 2020 Q2 | -23.17 Thousand CAD | -26.91% |
| 2019 Q1 | -14.2 Thousand CAD | -101.06% |
| 2019 FY | - USD | 92.2% |
| 2019 Q4 | -38.87 Thousand CAD | -435.16% |
| 2019 Q3 | -7264.00 CAD | 42.88% |
| 2019 Q2 | -12.71 Thousand CAD | 10.46% |
| 2018 FY | - CAD | 63.97% |
| 2018 Q4 | 1.34 Million CAD | 407.98% |
| 2018 Q3 | -435.8 Thousand CAD | 36.3% |
| 2018 Q2 | -684.17 Thousand CAD | 31.21% |
| 2018 Q1 | -994.59 Thousand CAD | -28.45% |
| 2017 Q1 | -435.87 Thousand CAD | -57.93% |
| 2017 Q3 | -501.59 Thousand CAD | 30.0% |
| 2017 FY | - CAD | -65.62% |
| 2017 Q2 | -716.52 Thousand CAD | -64.39% |
| 2017 Q4 | -774.32 Thousand CAD | -54.37% |
| 2016 Q4 | -275.98 Thousand CAD | 15.89% |
| 2016 Q2 | -412.47 Thousand CAD | 23.64% |
| 2016 Q1 | -540.14 Thousand CAD | -270.16% |
| 2016 FY | - CAD | -89.48% |
| 2016 Q3 | -328.12 Thousand CAD | 20.45% |
| 2015 Q2 | -228.83 Thousand CAD | -73.71% |
| 2015 Q4 | -145.92 Thousand CAD | 41.49% |
| 2015 Q3 | -249.39 Thousand CAD | -8.98% |
| 2015 FY | - CAD | -179.67% |
| 2015 Q1 | -131.73 Thousand CAD | -63.49% |
| 2014 Q3 | -111.24 Thousand CAD | -92.72% |
| 2014 Q2 | -57.72 Thousand CAD | -35.74% |
| 2014 Q1 | -42.52 Thousand CAD | 93.81% |
| 2014 FY | - CAD | 17.3% |
| 2014 Q4 | -80.57 Thousand CAD | 27.57% |
| 2013 Q3 | -38.38 Thousand CAD | 69.77% |
| 2013 FY | - CAD | -24.57% |
| 2013 Q1 | -23.92 Thousand CAD | 24.7% |
| 2013 Q2 | -126.96 Thousand CAD | -430.74% |
| 2013 Q4 | -687.38 Thousand CAD | -1690.99% |
| 2012 Q4 | -31.77 Thousand CAD | 17.67% |
| 2012 Q1 | -73.4 Thousand CAD | 16.37% |
| 2012 Q2 | -74.04 Thousand CAD | -0.86% |
| 2012 Q3 | -38.59 Thousand CAD | 47.88% |
| 2012 FY | - CAD | 6.85% |
| 2011 Q4 | -87.77 Thousand CAD | -44.09% |
| 2011 FY | - CAD | -990.68% |
| 2011 Q1 | -35.35 Thousand CAD | -162.55% |
| 2011 Q3 | -60.91 Thousand CAD | -33.34% |
| 2011 Q2 | -45.68 Thousand CAD | -29.23% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | -7.00 CAD | 0.0% |
| 2010 Q3 | -7571.00 CAD | -108057.14% |
| 2010 Q4 | -13.46 Thousand CAD | -77.85% |
| 2009 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 93.292% |
| IR-Med Inc. | -4.89 Million USD | 99.624% |
| Polarean Imaging plc | -11.19 Million USD | 99.836% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 104.035% |
| Avitar, Inc. | -1.66 Million USD | 98.897% |
| AVITA Medical, Inc. | -39.56 Million USD | 99.953% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 98.419% |
| Össur hf. | 137.38 Million USD | 100.013% |
| Zecotek Photonics Inc. | -3.44 Million USD | 99.465% |
| QHSLab, Inc. | -91.29 Thousand USD | 79.845% |
| Wellstar International, Inc. | -1.35 Million USD | 98.644% |
| Össur hf. | 137.38 Million USD | 100.013% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.188% |
| Escalon Medical Corp. | -58.46 Thousand USD | 68.526% |
| Aurora Spine Corporation | -454.37 Thousand USD | 95.951% |
| BrainsWay Ltd. | -2.31 Million USD | 99.204% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 99.804% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 100.333% |
| Vivos Inc. | -2.79 Million USD | 99.341% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.995% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 90.693% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 98.897% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 95.144% |
| Nanomix Corporation | -8.13 Million USD | 99.774% |
| Theraclion SA | -2.05 Million USD | 99.103% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 97.398% |
| Positron Corporation | -1.45 Million USD | 98.733% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 98.931% |
| Lombard Medical, Inc. | -28.06 Million USD | 99.934% |
| ALR Technologies Inc. | -6.4 Million USD | 99.713% |
| Stratec SE | 39.91 Million USD | 100.046% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 118.228% |
| Heart Tronics, Inc. | -14.85 Million USD | 99.876% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 84.441% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 99.861% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 99.799% |
| VMS Rehab Systems, Inc. | -68.55 USD | -26741.721% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 99.411% |
| Ingen Technologies, Inc. | -8639.00 USD | -112.988% |
| Odyssey Group International, Inc. | -2.13 Million USD | 99.139% |
| United American Healthcare Corporation | -59 Thousand USD | 68.814% |
| ECGI Holdings, Inc. | -2.99 Million USD | 99.385% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 97.076% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 96.42% |
| Urologix, Inc. | -6.34 Million USD | 99.71% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 98.515% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 97.598% |
| SS Innovations International, Inc. | -20.37 Million USD | 99.91% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 91.742% |
| Smith & Nephew plc | 1 Billion USD | 100.002% |
| NIOX Group Plc | 11.07 Million USD | 100.166% |
| Fuse Medical, Inc. | 1.83 Million USD | 101.003% |
| Broncus Holding Corporation | -25.19 Million USD | 99.927% |
| Brain Scientific Inc. | -7.93 Million USD | 99.768% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 99.804% |